National Research Co. (NASDAQ:NRCIA) Director John N. Nunnelly sold 612 shares of the business’s stock in a transaction that occurred on Tuesday, March 20th. The shares were sold at an average price of $31.40, for a total transaction of $19,216.80. Following the completion of the sale, the director now directly owns 36,133 shares in the company, valued at approximately $1,134,576.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

National Research stock traded down $0.40 during trading on Thursday, reaching $30.80. 8,942 shares of the company were exchanged, compared to its average volume of 20,636. The company has a market cap of $759.83, a price-to-earnings ratio of 59.23 and a beta of 1.75. National Research Co. has a twelve month low of $18.81 and a twelve month high of $41.99.

How to Become a New Pot Stock Millionaire

The company also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Friday, March 30th will be issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Wednesday, March 28th. National Research’s dividend payout ratio (DPR) is presently 76.92%.

A number of institutional investors have recently bought and sold shares of NRCIA. California Public Employees Retirement System grew its stake in National Research by 4.4% in the 4th quarter. California Public Employees Retirement System now owns 43,779 shares of the business services provider’s stock worth $1,633,000 after buying an additional 1,850 shares in the last quarter. Strs Ohio grew its stake in National Research by 12.7% in the 4th quarter. Strs Ohio now owns 20,400 shares of the business services provider’s stock worth $760,000 after buying an additional 2,300 shares in the last quarter. BlackRock Inc. grew its stake in National Research by 0.6% in the 4th quarter. BlackRock Inc. now owns 476,279 shares of the business services provider’s stock worth $17,765,000 after buying an additional 2,620 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in National Research by 58.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 8,412 shares of the business services provider’s stock worth $314,000 after buying an additional 3,094 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in National Research by 3.6% in the 4th quarter. Geode Capital Management LLC now owns 92,696 shares of the business services provider’s stock worth $3,457,000 after buying an additional 3,191 shares in the last quarter. 33.66% of the stock is currently owned by institutional investors and hedge funds.

NRCIA has been the topic of a number of analyst reports. Zacks Investment Research raised shares of National Research from a “strong sell” rating to a “hold” rating in a report on Wednesday, January 10th. BidaskClub raised shares of National Research from a “hold” rating to a “buy” rating in a report on Wednesday, December 27th.

TRADEMARK VIOLATION WARNING: “National Research Co. (NRCIA) Director Sells $19,216.80 in Stock” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.watchlistnews.com/national-research-co-nrcia-director-sells-19216-80-in-stock/1958126.html.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Insider Buying and Selling by Quarter for National Research (NASDAQ:NRCIA)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.